Annual Shareholders Equity
$493.40 M
-$106.10 M-17.70%
December 31, 2024
Summary
- As of March 8, 2025, VERV annual stockholders equity is $493.40 million, with the most recent change of -$106.10 million (-17.70%) on December 31, 2024.
- During the last 3 years, VERV annual shareholders equity has risen by +$136.05 million (+38.07%).
- VERV annual shareholders equity is now -17.70% below its all-time high of $599.50 million, reached on December 31, 2023.
Performance
VERV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$493.40 M
-$15.15 M-2.98%
December 1, 2024
Summary
- As of March 8, 2025, VERV quarterly stockholders equity is $493.40 million, with the most recent change of -$15.15 million (-2.98%) on December 1, 2024.
- Over the past year, VERV quarterly shareholders equity has dropped by -$106.10 million (-17.70%).
- VERV quarterly shareholders equity is now -17.70% below its all-time high of $599.50 million, reached on December 31, 2023.
Performance
VERV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VERV Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.7% | -17.7% |
| 3 y3 years | +38.1% | +7.2% |
| 5 y5 years | +2623.4% | +7.2% |
VERV Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.7% | +38.1% | -17.7% | +66.5% |
| 5 y | 5-year | -17.7% | +872.0% | -17.7% | +745.5% |
| alltime | all time | -17.7% | +872.0% | -17.7% | +745.5% |
Verve Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $493.40 M(-17.7%) | - |
| Dec 2024 | - | $493.40 M(-3.0%) |
| Sep 2024 | - | $508.55 M(-6.9%) |
| Jun 2024 | - | $546.09 M(-6.3%) |
| Mar 2024 | - | $583.07 M(-2.7%) |
| Dec 2023 | $599.50 M(+8.8%) | $599.50 M(+30.2%) |
| Sep 2023 | - | $460.37 M(-1.0%) |
| Jun 2023 | - | $465.22 M(-8.7%) |
| Mar 2023 | - | $509.48 M(-7.5%) |
| Dec 2022 | $550.93 M | $550.93 M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $547.94 M(+84.9%) |
| Jun 2022 | - | $296.33 M(-10.6%) |
| Mar 2022 | - | $331.39 M(-7.3%) |
| Dec 2021 | $357.35 M(-659.2%) | $357.35 M(-7.2%) |
| Sep 2021 | - | $384.94 M(-5.0%) |
| Jun 2021 | - | $405.40 M(-630.4%) |
| Mar 2021 | - | -$76.43 M(+19.6%) |
| Dec 2020 | -$63.91 M(+226.9%) | - |
| Dec 2020 | - | -$63.91 M |
| Dec 2019 | -$19.55 M | - |
FAQ
- What is Verve Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Verve Therapeutics?
- What is Verve Therapeutics annual shareholders equity year-on-year change?
- What is Verve Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Verve Therapeutics?
- What is Verve Therapeutics quarterly shareholders equity year-on-year change?
What is Verve Therapeutics annual stockholders equity?
The current annual shareholders equity of VERV is $493.40 M
What is the all time high annual shareholders equity for Verve Therapeutics?
Verve Therapeutics all-time high annual stockholders equity is $599.50 M
What is Verve Therapeutics annual shareholders equity year-on-year change?
Over the past year, VERV annual stockholders equity has changed by -$106.10 M (-17.70%)
What is Verve Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VERV is $493.40 M
What is the all time high quarterly shareholders equity for Verve Therapeutics?
Verve Therapeutics all-time high quarterly stockholders equity is $599.50 M
What is Verve Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VERV quarterly stockholders equity has changed by -$106.10 M (-17.70%)